Autres langues

17/09 Lavipharm S.A. Reports Earnings Results for the Half Year Ended June 30, 2026
03/09 Lavipharm S A : Announcement Appointment of Chief Manufacturing & Operations Officer
25/06 Lavipharm S.A. announces Annual dividend, payable on July 24, 2026
11/06 Lavipharm S A : Announcement Appointment of Chief Quality Officer
28/05 Lavipharm Q1 earnings before tax from continuing operations EUR1.41 million, up 28.6% Y/Y
28/05 Lavipharm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026
22/05 Lavipharm S A : IMPORTANT CORPORATE EVENTS
09/04 Lavipharm to acquire Durogesic pain patch rights from Janssen for $12.0 million
19/03 Lavipharm SA FY 2025 earnings after tax EUR 6.0 million versus EUR 9.0 million year ago
19/03 Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2025
17/11 Lavipharm 9-month net profit down to EUR 3.5 million
07/11 Lavipharm S A : OTHER ANNOUNCEMENTS
15/10/25 Lavipharm S A : ANNOUNCEMENT OF REGULATED INFORMATION - TRANSACTIONS NOTIFICATION
13/10/25 Lavipharm S A : ANNOUNCEMENT OF REGULATED INFORMATION - TRANSACTIONS NOTIFICATION
18/09/25 Lavipharm H1 adjusted EBITDA at EUR 7.7 million, up 29.4% Y/Y
18/09/25 Lavipharm S A : FINANCIAL RESULTS PRESS RELEASE FIRST HALF 2025
18/09/25 Lavipharm S.A. Reports Earnings Results for the Half Year Ended June 30, 2025
15/07/25 Lavipharm S A : CORPORATE ACTIONS
03/07/25 Lavipharm S.A. announces Annual dividend, payable on July 24, 2025
11/06/25 Lavipharm S A : Announcement 4310/2025
15/05/25 Lavipharm Q1 Net Profit At EUR 1.6 Million, Up 46.8% YoY
08/05/25 Lavipharm S A : Announcement of New Head of Corporate Announcements
14/04/25 Lavipharm And Tikun Olam Europe Launch Joint Telemedicine Company
14/04/25 Lavipharm S A : Announcement 2561/2025
19/03/25 Lavipharm FY 2024 Earnings After Tax EUR 9.0 Million Versus EUR 1.87 Million Year Ago
Aucun résultat pour cette recherche